Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BX005-A in moderate to severe atopic dermatitis
NCT05240300Phase 2Withdrawn
- Sponsor
- BiomX
- Start
- May 2022
- Primary completion
- Jun 2023
- Modality
- Single Strain Products, Multi-strain Products
01
Overview
A Phase 2 trial of BX005 in atopic dermatitis (AD), sponsored by BiomX. Planned start May 2022; status: withdrawn.
02
Drugs
BX005
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT05240300.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05240300.